Jpmorgan Chase & CO Alpha Tau Medical Ltd. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$955,7800.07% of portfolio
-
Hoyle Cohen, LLC269KShares$836,8630.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$717,4890.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$206,2730.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$166,7140.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $215M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...